ClinicalTrials.gov
public full text
Public Domain
Vildagliptin vs. Glibenclamide in Endothelial Function in Type 2 Diabetes and Hypertension
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effect of Vildagliptin vs. Glibenclamide on Circulating Endothelial Progenitor Cell Number Type 2 Diabetes#184791
- Vildagliptin Glycemic Profiles Assessment Using a Continuous Glucose Monitoring Device.#884134
- A Study of CIN-107 in Adults With Treatment-Resistant Hypertension (rHTN)#1114608
- Plasma Angiotensin II Levels In Women With Type 2 Diabetes With Or Without Hypertension#930366
- Pharmacokinetics of Vildagliptin in Mild, Moderate and Severe Renal Impaired Patients#880552
Record · ID 221633
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive